190 related articles for article (PubMed ID: 27317434)
1. USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma.
Engel K; Rudelius M; Slawska J; Jacobs L; Ahangarian Abhari B; Altmann B; Kurutz J; Rathakrishnan A; Fernández-Sáiz V; Brunner A; Targosz BS; Loewecke F; Gloeckner CJ; Ueffing M; Fulda S; Pfreundschuh M; Trümper L; Klapper W; Keller U; Jost PJ; Rosenwald A; Peschel C; Bassermann F
EMBO Mol Med; 2016 Aug; 8(8):851-62. PubMed ID: 27317434
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis.
Liu Y; Xu X; Lin P; He Y; Zhang Y; Cao B; Zhang Z; Sethi G; Liu J; Zhou X; Mao X
J Biol Chem; 2019 Mar; 294(12):4572-4582. PubMed ID: 30718275
[TBL] [Abstract][Full Text] [Related]
3. USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis.
Shang Z; Zhao J; Zhang Q; Cao C; Tian S; Zhang K; Liu L; Shi L; Yu N; Yang S
J Biol Chem; 2019 Jun; 294(25):9844-9857. PubMed ID: 31073027
[TBL] [Abstract][Full Text] [Related]
4. Antagonistic activities of CDC14B and CDK1 on USP9X regulate WT1-dependent mitotic transcription and survival.
Dietachmayr M; Rathakrishnan A; Karpiuk O; von Zweydorf F; Engleitner T; Fernández-Sáiz V; Schenk P; Ueffing M; Rad R; Eilers M; Gloeckner CJ; Clemm von Hohenberg K; Bassermann F
Nat Commun; 2020 Mar; 11(1):1268. PubMed ID: 32152317
[TBL] [Abstract][Full Text] [Related]
5. USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells.
Lu Q; Zhang FL; Lu DY; Shao ZM; Li DQ
Cancer Med; 2019 Nov; 8(15):6730-6740. PubMed ID: 31512408
[TBL] [Abstract][Full Text] [Related]
6. The deubiquitinase USP9X promotes tumor cell survival and confers chemoresistance through YAP1 stabilization.
Li L; Liu T; Li Y; Wu C; Luo K; Yin Y; Chen Y; Nowsheen S; Wu J; Lou Z; Yuan J
Oncogene; 2018 May; 37(18):2422-2431. PubMed ID: 29449692
[TBL] [Abstract][Full Text] [Related]
7. Targeting of the deubiquitinase USP9X attenuates B-cell acute lymphoblastic leukemia cell survival and overcomes glucocorticoid resistance.
Zhou M; Wang T; Lai H; Zhao X; Yu Q; Zhou J; Yang Y
Biochem Biophys Res Commun; 2015 Apr; 459(2):333-339. PubMed ID: 25735983
[TBL] [Abstract][Full Text] [Related]
8. Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies.
Peterson LF; Sun H; Liu Y; Potu H; Kandarpa M; Ermann M; Courtney SM; Young M; Showalter HD; Sun D; Jakubowiak A; Malek SN; Talpaz M; Donato NJ
Blood; 2015 Jun; 125(23):3588-97. PubMed ID: 25814533
[TBL] [Abstract][Full Text] [Related]
9. Upon drug-induced apoptosis in lymphoma cells X-linked inhibitor of apoptosis (XIAP) translocates from the cytosol to the nucleus.
Nowak D; Boehrer S; Brieger A; Kim SZ; Schaaf S; Hoelzer D; Mitrou PS; Weidmann E; Chow KU
Leuk Lymphoma; 2004 Jul; 45(7):1429-36. PubMed ID: 15359644
[TBL] [Abstract][Full Text] [Related]
10. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth.
Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitylating enzyme USP9x regulates radiosensitivity in glioblastoma cells by Mcl-1-dependent and -independent mechanisms.
Wolfsperger F; Hogh-Binder SA; Schittenhelm J; Psaras T; Ritter V; Bornes L; Huber SM; Jendrossek V; Rudner J
Cell Death Dis; 2016 Jan; 7(1):e2039. PubMed ID: 26775694
[TBL] [Abstract][Full Text] [Related]
12. Deubiquitinase USP9X stabilizes RNA m
Wang P; Wang J; Yao S; Cui M; Cheng Y; Liu W; Gao Z; Hu J; Zhang J; Zhang H
J Biol Chem; 2023 Aug; 299(8):105055. PubMed ID: 37454738
[TBL] [Abstract][Full Text] [Related]
13. β-catenin is regulated by USP9x and mediates resistance to TRAIL-induced apoptosis in breast cancer.
Ouyang W; Zhang S; Yang B; Yang C; Zhang J; Zhou F; Xie C
Oncol Rep; 2016 Feb; 35(2):717-24. PubMed ID: 26717875
[TBL] [Abstract][Full Text] [Related]
14. USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells.
Chen Z; Wang HW; Wang S; Fan L; Feng S; Cai X; Peng C; Wu X; Lu J; Chen D; Chen Y; Wu W; Lu D; Liu N; You Y; Wang H
J Clin Invest; 2019 Apr; 129(5):2043-2055. PubMed ID: 30958800
[TBL] [Abstract][Full Text] [Related]
15. Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor Growth.
Pal A; Dziubinski M; Di Magliano MP; Simeone DM; Owens S; Thomas D; Peterson L; Potu H; Talpaz M; Donato NJ
Neoplasia; 2018 Feb; 20(2):152-164. PubMed ID: 29248719
[TBL] [Abstract][Full Text] [Related]
16. USP9X deubiquitinates and stabilizes CDC123 to promote breast carcinogenesis through regulating cell cycle.
Song N; Deng L; Zeng L; He L; Liu C; Liu L; Fu R
Mol Carcinog; 2023 Oct; 62(10):1487-1503. PubMed ID: 37314216
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the Ubiquitin-Specific Peptidase 9 X-Linked (USP9X) Gene is Associated with Upregulation of Cyclin D1 (CCND1) and Downregulation of Cyclin-Dependent Inhibitor Kinase 1A (CDKN1A) in Breast Cancer Tissue and Cell Lines.
Li H; Zheng B
Med Sci Monit; 2019 Jun; 25():4207-4216. PubMed ID: 31169265
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of deubiquitinases primes glioblastoma cells to apoptosis in vitro and in vivo.
Karpel-Massler G; Banu MA; Shu C; Halatsch ME; Westhoff MA; Bruce JN; Canoll P; Siegelin MD
Oncotarget; 2016 Mar; 7(11):12791-805. PubMed ID: 26872380
[TBL] [Abstract][Full Text] [Related]
19. USP9X Deubiquitylates DVL2 to Regulate WNT Pathway Specification.
Nielsen CP; Jernigan KK; Diggins NL; Webb DJ; MacGurn JA
Cell Rep; 2019 Jul; 28(4):1074-1089.e5. PubMed ID: 31340145
[TBL] [Abstract][Full Text] [Related]
20. USP9X controls translation efficiency via deubiquitination of eukaryotic translation initiation factor 4A1.
Li Z; Cheng Z; Raghothama C; Cui Z; Liu K; Li X; Jiang C; Jiang W; Tan M; Ni X; Pandey A; Liu JO; Dang Y
Nucleic Acids Res; 2018 Jan; 46(2):823-839. PubMed ID: 29228324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
